Capecitabine
- Product NDC
- 82249-210
- 11-digit product format
- 822490210
- Labeler code
- 82249
- Product ID
- 82249-210_5a175994-25a9-4271-957f-9d8cc02fbfce
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Capecitabine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- CivicaScript LLC
- Application
- ANDA207652
- Marketing category
- ANDA
- Marketing start
- 2025-06-26
- Substance
- CAPECITABINE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Capecitabine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CAPECITABINE | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6804DJ8Z9U |
| Rxcui | 200327, 200328 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 82249-210-12 | Capecitabine | 120 in 1 BOTTLE | TABLET, FILM COATED | 120 | | 3 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 82249-210-12 | 82249021012 | 120 TABLET, FILM COATED in 1 BOTTLE (82249-210-12) | 2025-06-26 | No | No | Current |